Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Bower

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 11, 2008
Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazoneGualberto Ruaño, James Bernene, Andreas Windemuth, et al.
Puerto Rico Health Sciences Journal|January 26, 2011
Exposure to non-therapeutic INR in a high risk cardiovascular patient: potential hazard reduction with genotype-guided warfarin (Coumadin) dosingRosángela Rodríguez-Vélez, Oscar J Ortiz-Rivera, Bruce Bower, et al.
Personalized Medicine|May 23, 2018
High carrier prevalence of combinatorial CYP2C9 and VKORC1 genotypes affecting warfarin dosingGualberto Ruaño, Paul D Thompson, David Villagra, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 11, 2008
Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazoneGualberto Ruaño, James Bernene, Andreas Windemuth, et al.
Puerto Rico Health Sciences Journal|January 26, 2011
Exposure to non-therapeutic INR in a high risk cardiovascular patient: potential hazard reduction with genotype-guided warfarin (Coumadin) dosingRosángela Rodríguez-Vélez, Oscar J Ortiz-Rivera, Bruce Bower, et al.
Personalized Medicine|May 23, 2018
High carrier prevalence of combinatorial CYP2C9 and VKORC1 genotypes affecting warfarin dosingGualberto Ruaño, Paul D Thompson, David Villagra, et al.
Pageof 2